Global Favipiravir Supply, Demand and Key Producers, 2024-2030

Global Favipiravir Supply, Demand and Key Producers, 2024-2030

Page: 107

Published Date: 27 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Favipiravir market size is expected to reach $ 67 million by 2030, rising at a market growth of -21.1% CAGR during the forecast period (2024-2030).

In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.

This report studies the global Favipiravir production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Favipiravir, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Favipiravir that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Favipiravir total production and demand, 2019-2030, (K Units)
Global Favipiravir total production value, 2019-2030, (USD Million)
Global Favipiravir production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Favipiravir consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Favipiravir domestic production, consumption, key domestic manufacturers and share
Global Favipiravir production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Favipiravir production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Favipiravir production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Favipiravir market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma and Hisun Pharm, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Favipiravir market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Favipiravir Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Favipiravir Market, Segmentation by Type
Brand Drug
Generic Drug

Global Favipiravir Market, Segmentation by Application
Influenza Viruses
COVID-19
Others

Companies Profiled:
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm

Key Questions Answered
1. How big is the global Favipiravir market?
2. What is the demand of the global Favipiravir market?
3. What is the year over year growth of the global Favipiravir market?
4. What is the production and production value of the global Favipiravir market?
5. Who are the key producers in the global Favipiravir market?
btl

Table of Contents

1 Supply Summary
1.1 Favipiravir Introduction
1.2 World Favipiravir Supply & Forecast
1.2.1 World Favipiravir Production Value (2019 & 2023 & 2030)
1.2.2 World Favipiravir Production (2019-2030)
1.2.3 World Favipiravir Pricing Trends (2019-2030)
1.3 World Favipiravir Production by Region (Based on Production Site)
1.3.1 World Favipiravir Production Value by Region (2019-2030)
1.3.2 World Favipiravir Production by Region (2019-2030)
1.3.3 World Favipiravir Average Price by Region (2019-2030)
1.3.4 North America Favipiravir Production (2019-2030)
1.3.5 Europe Favipiravir Production (2019-2030)
1.3.6 China Favipiravir Production (2019-2030)
1.3.7 Japan Favipiravir Production (2019-2030)
1.3.8 India Favipiravir Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Favipiravir Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Favipiravir Major Market Trends

2 Demand Summary
2.1 World Favipiravir Demand (2019-2030)
2.2 World Favipiravir Consumption by Region
2.2.1 World Favipiravir Consumption by Region (2019-2024)
2.2.2 World Favipiravir Consumption Forecast by Region (2025-2030)
2.3 United States Favipiravir Consumption (2019-2030)
2.4 China Favipiravir Consumption (2019-2030)
2.5 Europe Favipiravir Consumption (2019-2030)
2.6 Japan Favipiravir Consumption (2019-2030)
2.7 South Korea Favipiravir Consumption (2019-2030)
2.8 ASEAN Favipiravir Consumption (2019-2030)
2.9 India Favipiravir Consumption (2019-2030)

3 World Favipiravir Manufacturers Competitive Analysis
3.1 World Favipiravir Production Value by Manufacturer (2019-2024)
3.2 World Favipiravir Production by Manufacturer (2019-2024)
3.3 World Favipiravir Average Price by Manufacturer (2019-2024)
3.4 Favipiravir Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Favipiravir Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Favipiravir in 2023
3.5.3 Global Concentration Ratios (CR8) for Favipiravir in 2023
3.6 Favipiravir Market: Overall Company Footprint Analysis
3.6.1 Favipiravir Market: Region Footprint
3.6.2 Favipiravir Market: Company Product Type Footprint
3.6.3 Favipiravir Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Favipiravir Production Value Comparison
4.1.1 United States VS China: Favipiravir Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Favipiravir Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Favipiravir Production Comparison
4.2.1 United States VS China: Favipiravir Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Favipiravir Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Favipiravir Consumption Comparison
4.3.1 United States VS China: Favipiravir Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Favipiravir Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Favipiravir Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Favipiravir Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Favipiravir Production Value (2019-2024)
4.4.3 United States Based Manufacturers Favipiravir Production (2019-2024)
4.5 China Based Favipiravir Manufacturers and Market Share
4.5.1 China Based Favipiravir Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Favipiravir Production Value (2019-2024)
4.5.3 China Based Manufacturers Favipiravir Production (2019-2024)
4.6 Rest of World Based Favipiravir Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Favipiravir Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Favipiravir Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Favipiravir Production (2019-2024)

5 Market Analysis by Type
5.1 World Favipiravir Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Brand Drug
5.2.2 Generic Drug
5.3 Market Segment by Type
5.3.1 World Favipiravir Production by Type (2019-2030)
5.3.2 World Favipiravir Production Value by Type (2019-2030)
5.3.3 World Favipiravir Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Favipiravir Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Influenza Viruses
6.2.2 COVID-19
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Favipiravir Production by Application (2019-2030)
6.3.2 World Favipiravir Production Value by Application (2019-2030)
6.3.3 World Favipiravir Average Price by Application (2019-2030)

7 Company Profiles
7.1 ChemRar Group
7.1.1 ChemRar Group Details
7.1.2 ChemRar Group Major Business
7.1.3 ChemRar Group Favipiravir Product and Services
7.1.4 ChemRar Group Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 ChemRar Group Recent Developments/Updates
7.1.6 ChemRar Group Competitive Strengths & Weaknesses
7.2 Glenmark
7.2.1 Glenmark Details
7.2.2 Glenmark Major Business
7.2.3 Glenmark Favipiravir Product and Services
7.2.4 Glenmark Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Glenmark Recent Developments/Updates
7.2.6 Glenmark Competitive Strengths & Weaknesses
7.3 Fujifilm
7.3.1 Fujifilm Details
7.3.2 Fujifilm Major Business
7.3.3 Fujifilm Favipiravir Product and Services
7.3.4 Fujifilm Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Fujifilm Recent Developments/Updates
7.3.6 Fujifilm Competitive Strengths & Weaknesses
7.4 Dr. Reddy
7.4.1 Dr. Reddy Details
7.4.2 Dr. Reddy Major Business
7.4.3 Dr. Reddy Favipiravir Product and Services
7.4.4 Dr. Reddy Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Dr. Reddy Recent Developments/Updates
7.4.6 Dr. Reddy Competitive Strengths & Weaknesses
7.5 R-Pharma
7.5.1 R-Pharma Details
7.5.2 R-Pharma Major Business
7.5.3 R-Pharma Favipiravir Product and Services
7.5.4 R-Pharma Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 R-Pharma Recent Developments/Updates
7.5.6 R-Pharma Competitive Strengths & Weaknesses
7.6 Cipla
7.6.1 Cipla Details
7.6.2 Cipla Major Business
7.6.3 Cipla Favipiravir Product and Services
7.6.4 Cipla Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Cipla Recent Developments/Updates
7.6.6 Cipla Competitive Strengths & Weaknesses
7.7 Lupin
7.7.1 Lupin Details
7.7.2 Lupin Major Business
7.7.3 Lupin Favipiravir Product and Services
7.7.4 Lupin Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Lupin Recent Developments/Updates
7.7.6 Lupin Competitive Strengths & Weaknesses
7.8 Sun Pharma
7.8.1 Sun Pharma Details
7.8.2 Sun Pharma Major Business
7.8.3 Sun Pharma Favipiravir Product and Services
7.8.4 Sun Pharma Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Sun Pharma Recent Developments/Updates
7.8.6 Sun Pharma Competitive Strengths & Weaknesses
7.9 Hisun Pharm
7.9.1 Hisun Pharm Details
7.9.2 Hisun Pharm Major Business
7.9.3 Hisun Pharm Favipiravir Product and Services
7.9.4 Hisun Pharm Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Hisun Pharm Recent Developments/Updates
7.9.6 Hisun Pharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Favipiravir Industry Chain
8.2 Favipiravir Upstream Analysis
8.2.1 Favipiravir Core Raw Materials
8.2.2 Main Manufacturers of Favipiravir Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Favipiravir Production Mode
8.6 Favipiravir Procurement Model
8.7 Favipiravir Industry Sales Model and Sales Channels
8.7.1 Favipiravir Sales Model
8.7.2 Favipiravir Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Favipiravir Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Favipiravir Production Value by Region (2019-2024) & (USD Million)
Table 3. World Favipiravir Production Value by Region (2025-2030) & (USD Million)
Table 4. World Favipiravir Production Value Market Share by Region (2019-2024)
Table 5. World Favipiravir Production Value Market Share by Region (2025-2030)
Table 6. World Favipiravir Production by Region (2019-2024) & (K Units)
Table 7. World Favipiravir Production by Region (2025-2030) & (K Units)
Table 8. World Favipiravir Production Market Share by Region (2019-2024)
Table 9. World Favipiravir Production Market Share by Region (2025-2030)
Table 10. World Favipiravir Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Favipiravir Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Favipiravir Major Market Trends
Table 13. World Favipiravir Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Favipiravir Consumption by Region (2019-2024) & (K Units)
Table 15. World Favipiravir Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Favipiravir Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Favipiravir Producers in 2023
Table 18. World Favipiravir Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Favipiravir Producers in 2023
Table 20. World Favipiravir Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Favipiravir Company Evaluation Quadrant
Table 22. World Favipiravir Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Favipiravir Production Site of Key Manufacturer
Table 24. Favipiravir Market: Company Product Type Footprint
Table 25. Favipiravir Market: Company Product Application Footprint
Table 26. Favipiravir Competitive Factors
Table 27. Favipiravir New Entrant and Capacity Expansion Plans
Table 28. Favipiravir Mergers & Acquisitions Activity
Table 29. United States VS China Favipiravir Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Favipiravir Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Favipiravir Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Favipiravir Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Favipiravir Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Favipiravir Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Favipiravir Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Favipiravir Production Market Share (2019-2024)
Table 37. China Based Favipiravir Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Favipiravir Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Favipiravir Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Favipiravir Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Favipiravir Production Market Share (2019-2024)
Table 42. Rest of World Based Favipiravir Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Favipiravir Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Favipiravir Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Favipiravir Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Favipiravir Production Market Share (2019-2024)
Table 47. World Favipiravir Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Favipiravir Production by Type (2019-2024) & (K Units)
Table 49. World Favipiravir Production by Type (2025-2030) & (K Units)
Table 50. World Favipiravir Production Value by Type (2019-2024) & (USD Million)
Table 51. World Favipiravir Production Value by Type (2025-2030) & (USD Million)
Table 52. World Favipiravir Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Favipiravir Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Favipiravir Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Favipiravir Production by Application (2019-2024) & (K Units)
Table 56. World Favipiravir Production by Application (2025-2030) & (K Units)
Table 57. World Favipiravir Production Value by Application (2019-2024) & (USD Million)
Table 58. World Favipiravir Production Value by Application (2025-2030) & (USD Million)
Table 59. World Favipiravir Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Favipiravir Average Price by Application (2025-2030) & (US$/Unit)
Table 61. ChemRar Group Basic Information, Manufacturing Base and Competitors
Table 62. ChemRar Group Major Business
Table 63. ChemRar Group Favipiravir Product and Services
Table 64. ChemRar Group Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. ChemRar Group Recent Developments/Updates
Table 66. ChemRar Group Competitive Strengths & Weaknesses
Table 67. Glenmark Basic Information, Manufacturing Base and Competitors
Table 68. Glenmark Major Business
Table 69. Glenmark Favipiravir Product and Services
Table 70. Glenmark Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Glenmark Recent Developments/Updates
Table 72. Glenmark Competitive Strengths & Weaknesses
Table 73. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 74. Fujifilm Major Business
Table 75. Fujifilm Favipiravir Product and Services
Table 76. Fujifilm Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Fujifilm Recent Developments/Updates
Table 78. Fujifilm Competitive Strengths & Weaknesses
Table 79. Dr. Reddy Basic Information, Manufacturing Base and Competitors
Table 80. Dr. Reddy Major Business
Table 81. Dr. Reddy Favipiravir Product and Services
Table 82. Dr. Reddy Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Dr. Reddy Recent Developments/Updates
Table 84. Dr. Reddy Competitive Strengths & Weaknesses
Table 85. R-Pharma Basic Information, Manufacturing Base and Competitors
Table 86. R-Pharma Major Business
Table 87. R-Pharma Favipiravir Product and Services
Table 88. R-Pharma Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. R-Pharma Recent Developments/Updates
Table 90. R-Pharma Competitive Strengths & Weaknesses
Table 91. Cipla Basic Information, Manufacturing Base and Competitors
Table 92. Cipla Major Business
Table 93. Cipla Favipiravir Product and Services
Table 94. Cipla Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Cipla Recent Developments/Updates
Table 96. Cipla Competitive Strengths & Weaknesses
Table 97. Lupin Basic Information, Manufacturing Base and Competitors
Table 98. Lupin Major Business
Table 99. Lupin Favipiravir Product and Services
Table 100. Lupin Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Lupin Recent Developments/Updates
Table 102. Lupin Competitive Strengths & Weaknesses
Table 103. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Sun Pharma Major Business
Table 105. Sun Pharma Favipiravir Product and Services
Table 106. Sun Pharma Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Sun Pharma Recent Developments/Updates
Table 108. Hisun Pharm Basic Information, Manufacturing Base and Competitors
Table 109. Hisun Pharm Major Business
Table 110. Hisun Pharm Favipiravir Product and Services
Table 111. Hisun Pharm Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Global Key Players of Favipiravir Upstream (Raw Materials)
Table 113. Favipiravir Typical Customers
Table 114. Favipiravir Typical Distributors
List of Figure
Figure 1. Favipiravir Picture
Figure 2. World Favipiravir Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Favipiravir Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Favipiravir Production (2019-2030) & (K Units)
Figure 5. World Favipiravir Average Price (2019-2030) & (US$/Unit)
Figure 6. World Favipiravir Production Value Market Share by Region (2019-2030)
Figure 7. World Favipiravir Production Market Share by Region (2019-2030)
Figure 8. North America Favipiravir Production (2019-2030) & (K Units)
Figure 9. Europe Favipiravir Production (2019-2030) & (K Units)
Figure 10. China Favipiravir Production (2019-2030) & (K Units)
Figure 11. Japan Favipiravir Production (2019-2030) & (K Units)
Figure 12. India Favipiravir Production (2019-2030) & (K Units)
Figure 13. Favipiravir Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Favipiravir Consumption (2019-2030) & (K Units)
Figure 16. World Favipiravir Consumption Market Share by Region (2019-2030)
Figure 17. United States Favipiravir Consumption (2019-2030) & (K Units)
Figure 18. China Favipiravir Consumption (2019-2030) & (K Units)
Figure 19. Europe Favipiravir Consumption (2019-2030) & (K Units)
Figure 20. Japan Favipiravir Consumption (2019-2030) & (K Units)
Figure 21. South Korea Favipiravir Consumption (2019-2030) & (K Units)
Figure 22. ASEAN Favipiravir Consumption (2019-2030) & (K Units)
Figure 23. India Favipiravir Consumption (2019-2030) & (K Units)
Figure 24. Producer Shipments of Favipiravir by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Favipiravir Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Favipiravir Markets in 2023
Figure 27. United States VS China: Favipiravir Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Favipiravir Production Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Favipiravir Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States Based Manufacturers Favipiravir Production Market Share 2023
Figure 31. China Based Manufacturers Favipiravir Production Market Share 2023
Figure 32. Rest of World Based Manufacturers Favipiravir Production Market Share 2023
Figure 33. World Favipiravir Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 34. World Favipiravir Production Value Market Share by Type in 2023
Figure 35. Brand Drug
Figure 36. Generic Drug
Figure 37. World Favipiravir Production Market Share by Type (2019-2030)
Figure 38. World Favipiravir Production Value Market Share by Type (2019-2030)
Figure 39. World Favipiravir Average Price by Type (2019-2030) & (US$/Unit)
Figure 40. World Favipiravir Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Favipiravir Production Value Market Share by Application in 2023
Figure 42. Influenza Viruses
Figure 43. COVID-19
Figure 44. Others
Figure 45. World Favipiravir Production Market Share by Application (2019-2030)
Figure 46. World Favipiravir Production Value Market Share by Application (2019-2030)
Figure 47. World Favipiravir Average Price by Application (2019-2030) & (US$/Unit)
Figure 48. Favipiravir Industry Chain
Figure 49. Favipiravir Procurement Model
Figure 50. Favipiravir Sales Model
Figure 51. Favipiravir Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Favipiravir Supply, Demand and Key Producers, 2024-2030

Global Favipiravir Supply, Demand and Key Producers, 2024-2030

Page: 107

Published Date: 27 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Favipiravir market size is expected to reach $ 67 million by 2030, rising at a market growth of -21.1% CAGR during the forecast period (2024-2030).

In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.

This report studies the global Favipiravir production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Favipiravir, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Favipiravir that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Favipiravir total production and demand, 2019-2030, (K Units)
Global Favipiravir total production value, 2019-2030, (USD Million)
Global Favipiravir production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Favipiravir consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Favipiravir domestic production, consumption, key domestic manufacturers and share
Global Favipiravir production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Favipiravir production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Favipiravir production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Favipiravir market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma, Cipla, Lupin, Sun Pharma and Hisun Pharm, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Favipiravir market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Favipiravir Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Favipiravir Market, Segmentation by Type
Brand Drug
Generic Drug

Global Favipiravir Market, Segmentation by Application
Influenza Viruses
COVID-19
Others

Companies Profiled:
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm

Key Questions Answered
1. How big is the global Favipiravir market?
2. What is the demand of the global Favipiravir market?
3. What is the year over year growth of the global Favipiravir market?
4. What is the production and production value of the global Favipiravir market?
5. Who are the key producers in the global Favipiravir market?
btl

Table of Contents

1 Supply Summary
1.1 Favipiravir Introduction
1.2 World Favipiravir Supply & Forecast
1.2.1 World Favipiravir Production Value (2019 & 2023 & 2030)
1.2.2 World Favipiravir Production (2019-2030)
1.2.3 World Favipiravir Pricing Trends (2019-2030)
1.3 World Favipiravir Production by Region (Based on Production Site)
1.3.1 World Favipiravir Production Value by Region (2019-2030)
1.3.2 World Favipiravir Production by Region (2019-2030)
1.3.3 World Favipiravir Average Price by Region (2019-2030)
1.3.4 North America Favipiravir Production (2019-2030)
1.3.5 Europe Favipiravir Production (2019-2030)
1.3.6 China Favipiravir Production (2019-2030)
1.3.7 Japan Favipiravir Production (2019-2030)
1.3.8 India Favipiravir Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Favipiravir Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Favipiravir Major Market Trends

2 Demand Summary
2.1 World Favipiravir Demand (2019-2030)
2.2 World Favipiravir Consumption by Region
2.2.1 World Favipiravir Consumption by Region (2019-2024)
2.2.2 World Favipiravir Consumption Forecast by Region (2025-2030)
2.3 United States Favipiravir Consumption (2019-2030)
2.4 China Favipiravir Consumption (2019-2030)
2.5 Europe Favipiravir Consumption (2019-2030)
2.6 Japan Favipiravir Consumption (2019-2030)
2.7 South Korea Favipiravir Consumption (2019-2030)
2.8 ASEAN Favipiravir Consumption (2019-2030)
2.9 India Favipiravir Consumption (2019-2030)

3 World Favipiravir Manufacturers Competitive Analysis
3.1 World Favipiravir Production Value by Manufacturer (2019-2024)
3.2 World Favipiravir Production by Manufacturer (2019-2024)
3.3 World Favipiravir Average Price by Manufacturer (2019-2024)
3.4 Favipiravir Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Favipiravir Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Favipiravir in 2023
3.5.3 Global Concentration Ratios (CR8) for Favipiravir in 2023
3.6 Favipiravir Market: Overall Company Footprint Analysis
3.6.1 Favipiravir Market: Region Footprint
3.6.2 Favipiravir Market: Company Product Type Footprint
3.6.3 Favipiravir Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Favipiravir Production Value Comparison
4.1.1 United States VS China: Favipiravir Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Favipiravir Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Favipiravir Production Comparison
4.2.1 United States VS China: Favipiravir Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Favipiravir Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Favipiravir Consumption Comparison
4.3.1 United States VS China: Favipiravir Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Favipiravir Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Favipiravir Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Favipiravir Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Favipiravir Production Value (2019-2024)
4.4.3 United States Based Manufacturers Favipiravir Production (2019-2024)
4.5 China Based Favipiravir Manufacturers and Market Share
4.5.1 China Based Favipiravir Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Favipiravir Production Value (2019-2024)
4.5.3 China Based Manufacturers Favipiravir Production (2019-2024)
4.6 Rest of World Based Favipiravir Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Favipiravir Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Favipiravir Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Favipiravir Production (2019-2024)

5 Market Analysis by Type
5.1 World Favipiravir Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Brand Drug
5.2.2 Generic Drug
5.3 Market Segment by Type
5.3.1 World Favipiravir Production by Type (2019-2030)
5.3.2 World Favipiravir Production Value by Type (2019-2030)
5.3.3 World Favipiravir Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Favipiravir Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Influenza Viruses
6.2.2 COVID-19
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Favipiravir Production by Application (2019-2030)
6.3.2 World Favipiravir Production Value by Application (2019-2030)
6.3.3 World Favipiravir Average Price by Application (2019-2030)

7 Company Profiles
7.1 ChemRar Group
7.1.1 ChemRar Group Details
7.1.2 ChemRar Group Major Business
7.1.3 ChemRar Group Favipiravir Product and Services
7.1.4 ChemRar Group Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 ChemRar Group Recent Developments/Updates
7.1.6 ChemRar Group Competitive Strengths & Weaknesses
7.2 Glenmark
7.2.1 Glenmark Details
7.2.2 Glenmark Major Business
7.2.3 Glenmark Favipiravir Product and Services
7.2.4 Glenmark Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Glenmark Recent Developments/Updates
7.2.6 Glenmark Competitive Strengths & Weaknesses
7.3 Fujifilm
7.3.1 Fujifilm Details
7.3.2 Fujifilm Major Business
7.3.3 Fujifilm Favipiravir Product and Services
7.3.4 Fujifilm Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Fujifilm Recent Developments/Updates
7.3.6 Fujifilm Competitive Strengths & Weaknesses
7.4 Dr. Reddy
7.4.1 Dr. Reddy Details
7.4.2 Dr. Reddy Major Business
7.4.3 Dr. Reddy Favipiravir Product and Services
7.4.4 Dr. Reddy Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Dr. Reddy Recent Developments/Updates
7.4.6 Dr. Reddy Competitive Strengths & Weaknesses
7.5 R-Pharma
7.5.1 R-Pharma Details
7.5.2 R-Pharma Major Business
7.5.3 R-Pharma Favipiravir Product and Services
7.5.4 R-Pharma Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 R-Pharma Recent Developments/Updates
7.5.6 R-Pharma Competitive Strengths & Weaknesses
7.6 Cipla
7.6.1 Cipla Details
7.6.2 Cipla Major Business
7.6.3 Cipla Favipiravir Product and Services
7.6.4 Cipla Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Cipla Recent Developments/Updates
7.6.6 Cipla Competitive Strengths & Weaknesses
7.7 Lupin
7.7.1 Lupin Details
7.7.2 Lupin Major Business
7.7.3 Lupin Favipiravir Product and Services
7.7.4 Lupin Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Lupin Recent Developments/Updates
7.7.6 Lupin Competitive Strengths & Weaknesses
7.8 Sun Pharma
7.8.1 Sun Pharma Details
7.8.2 Sun Pharma Major Business
7.8.3 Sun Pharma Favipiravir Product and Services
7.8.4 Sun Pharma Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Sun Pharma Recent Developments/Updates
7.8.6 Sun Pharma Competitive Strengths & Weaknesses
7.9 Hisun Pharm
7.9.1 Hisun Pharm Details
7.9.2 Hisun Pharm Major Business
7.9.3 Hisun Pharm Favipiravir Product and Services
7.9.4 Hisun Pharm Favipiravir Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Hisun Pharm Recent Developments/Updates
7.9.6 Hisun Pharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Favipiravir Industry Chain
8.2 Favipiravir Upstream Analysis
8.2.1 Favipiravir Core Raw Materials
8.2.2 Main Manufacturers of Favipiravir Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Favipiravir Production Mode
8.6 Favipiravir Procurement Model
8.7 Favipiravir Industry Sales Model and Sales Channels
8.7.1 Favipiravir Sales Model
8.7.2 Favipiravir Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Favipiravir Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Favipiravir Production Value by Region (2019-2024) & (USD Million)
Table 3. World Favipiravir Production Value by Region (2025-2030) & (USD Million)
Table 4. World Favipiravir Production Value Market Share by Region (2019-2024)
Table 5. World Favipiravir Production Value Market Share by Region (2025-2030)
Table 6. World Favipiravir Production by Region (2019-2024) & (K Units)
Table 7. World Favipiravir Production by Region (2025-2030) & (K Units)
Table 8. World Favipiravir Production Market Share by Region (2019-2024)
Table 9. World Favipiravir Production Market Share by Region (2025-2030)
Table 10. World Favipiravir Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Favipiravir Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Favipiravir Major Market Trends
Table 13. World Favipiravir Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Favipiravir Consumption by Region (2019-2024) & (K Units)
Table 15. World Favipiravir Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Favipiravir Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Favipiravir Producers in 2023
Table 18. World Favipiravir Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Favipiravir Producers in 2023
Table 20. World Favipiravir Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Favipiravir Company Evaluation Quadrant
Table 22. World Favipiravir Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Favipiravir Production Site of Key Manufacturer
Table 24. Favipiravir Market: Company Product Type Footprint
Table 25. Favipiravir Market: Company Product Application Footprint
Table 26. Favipiravir Competitive Factors
Table 27. Favipiravir New Entrant and Capacity Expansion Plans
Table 28. Favipiravir Mergers & Acquisitions Activity
Table 29. United States VS China Favipiravir Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Favipiravir Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Favipiravir Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Favipiravir Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Favipiravir Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Favipiravir Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Favipiravir Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Favipiravir Production Market Share (2019-2024)
Table 37. China Based Favipiravir Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Favipiravir Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Favipiravir Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Favipiravir Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Favipiravir Production Market Share (2019-2024)
Table 42. Rest of World Based Favipiravir Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Favipiravir Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Favipiravir Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Favipiravir Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Favipiravir Production Market Share (2019-2024)
Table 47. World Favipiravir Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Favipiravir Production by Type (2019-2024) & (K Units)
Table 49. World Favipiravir Production by Type (2025-2030) & (K Units)
Table 50. World Favipiravir Production Value by Type (2019-2024) & (USD Million)
Table 51. World Favipiravir Production Value by Type (2025-2030) & (USD Million)
Table 52. World Favipiravir Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Favipiravir Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Favipiravir Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Favipiravir Production by Application (2019-2024) & (K Units)
Table 56. World Favipiravir Production by Application (2025-2030) & (K Units)
Table 57. World Favipiravir Production Value by Application (2019-2024) & (USD Million)
Table 58. World Favipiravir Production Value by Application (2025-2030) & (USD Million)
Table 59. World Favipiravir Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Favipiravir Average Price by Application (2025-2030) & (US$/Unit)
Table 61. ChemRar Group Basic Information, Manufacturing Base and Competitors
Table 62. ChemRar Group Major Business
Table 63. ChemRar Group Favipiravir Product and Services
Table 64. ChemRar Group Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. ChemRar Group Recent Developments/Updates
Table 66. ChemRar Group Competitive Strengths & Weaknesses
Table 67. Glenmark Basic Information, Manufacturing Base and Competitors
Table 68. Glenmark Major Business
Table 69. Glenmark Favipiravir Product and Services
Table 70. Glenmark Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Glenmark Recent Developments/Updates
Table 72. Glenmark Competitive Strengths & Weaknesses
Table 73. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 74. Fujifilm Major Business
Table 75. Fujifilm Favipiravir Product and Services
Table 76. Fujifilm Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Fujifilm Recent Developments/Updates
Table 78. Fujifilm Competitive Strengths & Weaknesses
Table 79. Dr. Reddy Basic Information, Manufacturing Base and Competitors
Table 80. Dr. Reddy Major Business
Table 81. Dr. Reddy Favipiravir Product and Services
Table 82. Dr. Reddy Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Dr. Reddy Recent Developments/Updates
Table 84. Dr. Reddy Competitive Strengths & Weaknesses
Table 85. R-Pharma Basic Information, Manufacturing Base and Competitors
Table 86. R-Pharma Major Business
Table 87. R-Pharma Favipiravir Product and Services
Table 88. R-Pharma Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. R-Pharma Recent Developments/Updates
Table 90. R-Pharma Competitive Strengths & Weaknesses
Table 91. Cipla Basic Information, Manufacturing Base and Competitors
Table 92. Cipla Major Business
Table 93. Cipla Favipiravir Product and Services
Table 94. Cipla Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Cipla Recent Developments/Updates
Table 96. Cipla Competitive Strengths & Weaknesses
Table 97. Lupin Basic Information, Manufacturing Base and Competitors
Table 98. Lupin Major Business
Table 99. Lupin Favipiravir Product and Services
Table 100. Lupin Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Lupin Recent Developments/Updates
Table 102. Lupin Competitive Strengths & Weaknesses
Table 103. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Sun Pharma Major Business
Table 105. Sun Pharma Favipiravir Product and Services
Table 106. Sun Pharma Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Sun Pharma Recent Developments/Updates
Table 108. Hisun Pharm Basic Information, Manufacturing Base and Competitors
Table 109. Hisun Pharm Major Business
Table 110. Hisun Pharm Favipiravir Product and Services
Table 111. Hisun Pharm Favipiravir Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Global Key Players of Favipiravir Upstream (Raw Materials)
Table 113. Favipiravir Typical Customers
Table 114. Favipiravir Typical Distributors
List of Figure
Figure 1. Favipiravir Picture
Figure 2. World Favipiravir Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Favipiravir Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Favipiravir Production (2019-2030) & (K Units)
Figure 5. World Favipiravir Average Price (2019-2030) & (US$/Unit)
Figure 6. World Favipiravir Production Value Market Share by Region (2019-2030)
Figure 7. World Favipiravir Production Market Share by Region (2019-2030)
Figure 8. North America Favipiravir Production (2019-2030) & (K Units)
Figure 9. Europe Favipiravir Production (2019-2030) & (K Units)
Figure 10. China Favipiravir Production (2019-2030) & (K Units)
Figure 11. Japan Favipiravir Production (2019-2030) & (K Units)
Figure 12. India Favipiravir Production (2019-2030) & (K Units)
Figure 13. Favipiravir Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Favipiravir Consumption (2019-2030) & (K Units)
Figure 16. World Favipiravir Consumption Market Share by Region (2019-2030)
Figure 17. United States Favipiravir Consumption (2019-2030) & (K Units)
Figure 18. China Favipiravir Consumption (2019-2030) & (K Units)
Figure 19. Europe Favipiravir Consumption (2019-2030) & (K Units)
Figure 20. Japan Favipiravir Consumption (2019-2030) & (K Units)
Figure 21. South Korea Favipiravir Consumption (2019-2030) & (K Units)
Figure 22. ASEAN Favipiravir Consumption (2019-2030) & (K Units)
Figure 23. India Favipiravir Consumption (2019-2030) & (K Units)
Figure 24. Producer Shipments of Favipiravir by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Favipiravir Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Favipiravir Markets in 2023
Figure 27. United States VS China: Favipiravir Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Favipiravir Production Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Favipiravir Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States Based Manufacturers Favipiravir Production Market Share 2023
Figure 31. China Based Manufacturers Favipiravir Production Market Share 2023
Figure 32. Rest of World Based Manufacturers Favipiravir Production Market Share 2023
Figure 33. World Favipiravir Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 34. World Favipiravir Production Value Market Share by Type in 2023
Figure 35. Brand Drug
Figure 36. Generic Drug
Figure 37. World Favipiravir Production Market Share by Type (2019-2030)
Figure 38. World Favipiravir Production Value Market Share by Type (2019-2030)
Figure 39. World Favipiravir Average Price by Type (2019-2030) & (US$/Unit)
Figure 40. World Favipiravir Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Favipiravir Production Value Market Share by Application in 2023
Figure 42. Influenza Viruses
Figure 43. COVID-19
Figure 44. Others
Figure 45. World Favipiravir Production Market Share by Application (2019-2030)
Figure 46. World Favipiravir Production Value Market Share by Application (2019-2030)
Figure 47. World Favipiravir Average Price by Application (2019-2030) & (US$/Unit)
Figure 48. Favipiravir Industry Chain
Figure 49. Favipiravir Procurement Model
Figure 50. Favipiravir Sales Model
Figure 51. Favipiravir Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
jiaGou

Add To Cart

gouMai

Buy Now